Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8791012 | American Journal of Ophthalmology Case Reports | 2018 | 7 Pages |
Abstract
and importance: To our knowledge, this is the third case of HLA-A29 negative BLCR associated with CVID. It is the first case with long-term follow-up providing, in consequence, the best understanding of the natural history and possible complications of this rare disease. Aggressive systemic treatment, in collaboration with an immunologist, is generally needed to control the ophthalmic complications.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Razek Georges Coussa, Fares Antaki, David E. Lederer,